• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Role of chronic Pseudomonas aeruginosa infection in the development of bronchiectasis.

作者信息

Nagaki M, Shimura S, Tanno Y, Ishibashi T, Sasaki H, Takishima T

机构信息

First Department of Internal Medicine, Tohoku University School of Medicine, Sendai, Japan.

出版信息

Chest. 1992 Nov;102(5):1464-9. doi: 10.1378/chest.102.5.1464.

DOI:10.1378/chest.102.5.1464
PMID:1424868
Abstract

To understand the role of Pseudomonas aeruginosa infection in the development of bronchiectasis, we investigated by CT the presence of bronchiectasis in two groups of chronic bronchitis patients and in a control group. There were no differences in clinical or laboratory findings between groups A and B. Three observers without any knowledge of these patients reported bronchiectasis on a scale of 0 to 3 and bronchial wall thickness on a scale of 0 to 3 in each lobe of both lungs. Bronchiectasis and wall thickness scores in group A (chronic bronchitis with P aeruginosa infection) were significantly higher than bronchiectasis scores and wall thickness in group B (chronic bronchitis without P aeruginosa infection). Both scores in group B were higher than those in group C (control group). These findings support the idea that chronic P aeruginosa infection plays a role in the development of bronchiectasis.

摘要

相似文献

1
Role of chronic Pseudomonas aeruginosa infection in the development of bronchiectasis.
Chest. 1992 Nov;102(5):1464-9. doi: 10.1378/chest.102.5.1464.
2
Effects of airway infection by Pseudomonas aeruginosa: a computed tomographic study.铜绿假单胞菌气道感染的影响:一项计算机断层扫描研究。
Thorax. 1997 Mar;52(3):260-4. doi: 10.1136/thx.52.3.260.
3
Bacterial bronchitis and bronchiectasis in human immunodeficiency virus infection.人类免疫缺陷病毒感染中的细菌性支气管炎和支气管扩张症
Arch Intern Med. 1994 Sep 26;154(18):2086-91.
4
Impact of chronic Pseudomonas aeruginosa infection on health-related quality of life in Mycobacterium avium complex lung disease.慢性铜绿假单胞菌感染对鸟分枝杆菌复合体肺病患者健康相关生活质量的影响。
BMC Pulm Med. 2017 Dec 13;17(1):198. doi: 10.1186/s12890-017-0544-x.
5
[Inhaled colistin in elderly patients with non-cystic fibrosis bronchiectasis and chronic Pseudomonas aeruginosa bronchial infection].吸入性黏菌素用于非囊性纤维化支气管扩张症合并慢性铜绿假单胞菌支气管感染的老年患者
Rev Esp Geriatr Gerontol. 2015 May-Jun;50(3):111-5. doi: 10.1016/j.regg.2014.09.005. Epub 2015 Feb 25.
6
Analysis of IgA antibody to Pseudomonas aeruginosa in sera and sputa of patients with chronic airway diseases.
Intern Med. 1992 May;31(5):575-82. doi: 10.2169/internalmedicine.31.575.
7
[Chronic bronchial infection: the problem of Pseudomonas aeruginosa].[慢性支气管感染:铜绿假单胞菌问题]
Arch Bronconeumol. 2011 Jun;47 Suppl 6:8-13. doi: 10.1016/S0300-2896(11)70029-1.
8
Characterization of bronchiectasis in the elderly.老年人支气管扩张的特征
Respir Med. 2016 Oct;119:13-19. doi: 10.1016/j.rmed.2016.08.008. Epub 2016 Aug 17.
9
Factors associated with lung function decline in adult patients with stable non-cystic fibrosis bronchiectasis.稳定期非囊性纤维化支气管扩张症成年患者肺功能下降的相关因素。
Chest. 2007 Nov;132(5):1565-72. doi: 10.1378/chest.07-0490.
10
Addition of inhaled tobramycin to ciprofloxacin for acute exacerbations of Pseudomonas aeruginosa infection in adult bronchiectasis.在成人支气管扩张症患者中,吸入妥布霉素联合环丙沙星用于治疗铜绿假单胞菌感染急性加重期。
Chest. 2006 Nov;130(5):1503-10. doi: 10.1378/chest.130.5.1503.

引用本文的文献

1
Nontuberculous Mycobacteria, Mucociliary Clearance, and Bronchiectasis.非结核分枝杆菌、黏液纤毛清除功能与支气管扩张症
Microorganisms. 2024 Mar 27;12(4):665. doi: 10.3390/microorganisms12040665.
2
Surgery for bronchiectasis-destroyed lung: feasibility of video-assisted thoracoscopic surgery, and surgical outcomes.支气管扩张毁损肺的手术治疗:电视辅助胸腔镜手术的可行性及手术效果
Interdiscip Cardiovasc Thorac Surg. 2024 Feb 2;38(2). doi: 10.1093/icvts/ivad175.
3
The Saudi Thoracic Society guidelines for diagnosis and management of noncystic fibrosis bronchiectasis.
沙特胸科学会非囊性纤维化支气管扩张症诊断与管理指南
Ann Thorac Med. 2017 Jul-Sep;12(3):135-161. doi: 10.4103/atm.ATM_171_17.
4
The development of selective inhibitors of NagZ: increased susceptibility of Gram-negative bacteria to β-lactams.NagZ 选择性抑制剂的开发:增加革兰氏阴性菌对β-内酰胺类抗生素的敏感性。
Chembiochem. 2013 Oct 11;14(15):1973-81. doi: 10.1002/cbic.201300395. Epub 2013 Sep 5.
5
Evolution and adaptation in Pseudomonas aeruginosa biofilms driven by mismatch repair system-deficient mutators.铜绿假单胞菌生物膜中的错配修复系统缺陷突变体的进化和适应
PLoS One. 2011;6(11):e27842. doi: 10.1371/journal.pone.0027842. Epub 2011 Nov 17.
6
Virtual screening of AmpC/β-lactamase as target for antimicrobial resistance in Pseudomonas aeruginosa.以AmpC/β-内酰胺酶为靶点对铜绿假单胞菌耐药性进行虚拟筛选
Bioinformation. 2010 Jan 17;4(7):290-4. doi: 10.6026/97320630004290.
7
Efficacy and potential for resistance selection of antipseudomonal treatments in a mouse model of lung infection by hypermutable Pseudomonas aeruginosa.高变异性铜绿假单胞菌肺部感染小鼠模型中抗假单胞菌治疗的疗效及耐药性选择潜力
Antimicrob Agents Chemother. 2006 Mar;50(3):975-83. doi: 10.1128/AAC.50.3.975-983.2006.
8
Molecular mechanisms of beta-lactam resistance mediated by AmpC hyperproduction in Pseudomonas aeruginosa clinical strains.铜绿假单胞菌临床菌株中AmpC高表达介导的β-内酰胺耐药的分子机制
Antimicrob Agents Chemother. 2005 Nov;49(11):4733-8. doi: 10.1128/AAC.49.11.4733-4738.2005.
9
Hypermutation is a key factor in development of multiple-antimicrobial resistance in Pseudomonas aeruginosa strains causing chronic lung infections.高突变是导致慢性肺部感染的铜绿假单胞菌菌株多重耐药性发展的关键因素。
Antimicrob Agents Chemother. 2005 Aug;49(8):3382-6. doi: 10.1128/AAC.49.8.3382-3386.2005.
10
Epidemiological analysis of sequential Pseudomonas aeruginosa isolates from chronic bronchiectasis patients without cystic fibrosis.对非囊性纤维化慢性支气管扩张症患者的铜绿假单胞菌连续分离株的流行病学分析
J Clin Microbiol. 1999 Jun;37(6):2071-3. doi: 10.1128/JCM.37.6.2071-2073.1999.